FeRiva 21/7
- Form
- Tablet
- Product type
- Other Combinations
- Serving size
- 1 tablets
Ingredients
Supplement Facts
- Serving size
- 1 tablets
| Ingredients | Amount | %DV |
|---|---|---|
| Vitamin CVitamin C | 175 mg | 292% |
| ZincZinc Bisglycinate | 10 mg | 67% |
| Vitamin B12Cyanocobalamin | 12 mcg | 200% |
| IronFerrous Asparto Glycinate | 75 mg | 417% |
| Folate (Folic Acid)(6S)-N5-Methyltetrahydrofolic Acid Calcium Salt | 1 mg | 250% |
| Folate (Folic Acid) | 400 mcg | — |
| Succinic Acid | 150 mg | — |
Show other ingredientsHide other ingredients2
Ingredients listed outside the Supplement Facts panel. Amounts and %DV are not required there, so they are not recorded.
| Ingredients | Form |
|---|---|
| Other Ingredients (Red Iron Tablets) | Coating Contains, Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid |
| Other Ingredients (Purple Inert Tablets) | Coating Contains, Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid |
Source: DSLD (US NIH) label ID 239383Amounts are as stated on the product label. Check the latest label before you buy.
Where to buy
"Search on …" opens a search by product name. Other products may appear, so check the name and size on the store page.
Intended for
- Adults
- Pregnant Women
- Lactating
Label directions and warnings
Quoted from the label as written. Marketing statements, such as claimed benefits, are not shown.
- Directions
- Dosage and Administration: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple inert tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple inert tablet daily for 7 days. After 28 tablets have been taken a new course maybe started if prescribed.
- Precautions
- Contraindications: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
- Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
- Precautions: children
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Keep out of reach of children.
- Precautions: pregnancy, nursing, medications
- While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.
- Precautions: allergies
- Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- Does not contain
- Purple Inert Tablets do not contain any vitamins, minerals or other dietary ingredients. Please see other ingredients section below for the listing of the inert ingredients.
- Storage
- Store betweed 20 degrees - 25 degrees C (68 degrees - 77 degrees F).